Skip to main content

Ewing Sarcoma Clinical Trials

Review the Ewing sarcoma clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 26-33 of 33

Tumor Infiltrating Lymphocytes for the Treatment of Children with High Risk Solid Tumors
Status: Active
Location: Johns Hopkins All Children's Hospital, Saint Petersburg, Florida
Biologically-Adapted, Dose-Escalated Radiotherapy for the Treatment of Ewing Sarcoma, BEAR Trial
Status: Active
Location: Mayo Clinic in Rochester, Rochester, Minnesota
PM14 Administered Intravenously to Patients with Advanced Solid Tumors
Status: Active
Location: See ClinicalTrials.gov
A Study of EGFR806 CAR T-Cell Immunotherapy for Treating Children and Young Adults with Recurrent/Refractory Solid Tumors
Status: Temporarily Closed to Accrual
Location: Fred Hutch/University of Washington/Seattle Children's Cancer Consortium, Seattle, Washington
Liquid Biopsy as a Prognostic and Response Diagnostic in Patients with Ewing Sarcoma and Osteosarcoma, LEOPARD Study
Status: Active
Location: 15 locations
89Zr-DFO-SC16.56 PET/CT for the Diagnosis of Neuroendocrine Tumors
Status: Active
Location: Memorial Sloan Kettering Cancer Center, New York, New York
Comparing Carbon Ion Therapy, Surgery, and Proton Therapy for the Management of Pelvic Sarcomas involving the Bone, the PROSPER Study
Status: Active
Location: 3 locations
An EHR-Based Comprehensive Bone and Soft Tissue Tumor Registry
Status: Active
Location: Ohio State University Comprehensive Cancer Center, Columbus, Ohio